Cargando…
Prognosis of Midkine and AT1R expression in resectable head and neck squamous cell carcinoma
BACKGROUND: Research studies have demonstrated that Midkine (MDK) can influence the expression and activity of Renin-angiotensin system (RAS) components. Angiotensin II is involved in tumor growth and angiogenesis in different cancers. We previously observed Angiotensin II receptor blockers (ARBs) i...
Autores principales: | Chiu, Tai-Jan, Chen, Chang-Han, Chen, Yi-Ju, Wee, Yinshen, Wang, Ching-Shuen, Luo, Sheng‑Dean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10518915/ https://www.ncbi.nlm.nih.gov/pubmed/37743493 http://dx.doi.org/10.1186/s12935-023-03060-z |
Ejemplares similares
-
Direct Oral Anticoagulants Are Associated with Superior Survival Outcomes than Warfarin in Patients with Head and Neck Cancers
por: Lee, Chien-Lin, et al.
Publicado: (2022) -
Serum midkine as a biomarker for malignancy, prognosis, and chemosensitivity in head and neck squamous cell carcinoma
por: Yamashita, Taku, et al.
Publicado: (2016) -
Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018) -
Proanthocyanidins-loaded complex coacervates-based drug delivery attenuates oral squamous cell carcinoma cells metastatic potential through down-regulating the Akt signaling pathway
por: Liu, Ju-Fang, et al.
Publicado: (2022) -
The Impact of Clinical Prognosis of Viral Hepatitis in Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
por: Wang, Yu-Ming, et al.
Publicado: (2023)